Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (59) 59
humans (58) 58
hematology (41) 41
male (41) 41
female (39) 39
middle aged (33) 33
adult (31) 31
stem cells (31) 31
transplantation (27) 27
bone marrow (24) 24
aged (23) 23
stromal cells (21) 21
stem-cells (19) 19
mesenchymal stromal cells - cytology (18) 18
oncology (17) 17
leukemia (15) 15
mesenchymal stromal cells (15) 15
analysis (14) 14
versus-host-disease (14) 14
cells, cultured (13) 13
hematology, oncology and palliative medicine (13) 13
animals (12) 12
cell biology (12) 12
medicine (12) 12
mesenchymal stem cells (12) 12
mesenchymal stromal cells - metabolism (11) 11
therapy (11) 11
transplantation, homologous (11) 11
bone marrow cells - cytology (10) 10
care and treatment (10) 10
differentiation (10) 10
expression (10) 10
immunology (10) 10
mesenchyme (10) 10
mice (10) 10
research (10) 10
treatment outcome (10) 10
adolescent (9) 9
cell proliferation (9) 9
chronic myeloid leukemia (9) 9
gene expression (9) 9
hematopoiesis (9) 9
medicine, research & experimental (9) 9
bone-marrow-transplantation (8) 8
cells (8) 8
cell cycle (7) 7
disease (7) 7
graft-versus-host disease (7) 7
hematopoietic stem cells (7) 7
research article (7) 7
young adult (7) 7
aged, 80 and over (6) 6
biocompatibility (6) 6
biotechnology & applied microbiology (6) 6
bone marrow cells - metabolism (6) 6
bone-marrow (6) 6
cell differentiation (6) 6
clinical trials (6) 6
flow cytometry (6) 6
patients (6) 6
progenitor cells (6) 6
regeneration (6) 6
risk factors (6) 6
advanced basic science (5) 5
antineoplastic agents - therapeutic use (5) 5
biomedical materials (5) 5
bone (5) 5
cancer (5) 5
cell & tissue engineering (5) 5
clinical-trials (5) 5
cord blood (5) 5
diagnosis (5) 5
expansion (5) 5
gene expression profiling (5) 5
immunophenotyping (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (5) 5
mesenchymal stem cell transplantation (5) 5
mesenchymal stromal cells - physiology (5) 5
multidisciplinary sciences (5) 5
myelodysplastic syndromes (5) 5
peripheral-blood (5) 5
phenotype (5) 5
science (5) 5
survival (5) 5
usage (5) 5
adipose tissue (4) 4
apoptosis (4) 4
biology (4) 4
bone marrow transplantation (4) 4
cell line, tumor (4) 4
cell survival (4) 4
chronic myelogenous leukemia (4) 4
coculture techniques (4) 4
complications (4) 4
criteria (4) 4
culture-conditions (4) 4
cytokines (4) 4
dasatinib (4) 4
dendritic cells (4) 4
extracellular vesicles (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34+ Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability
by Preciado, Silvia and Muntión, Sandra and Corchete, Luis A and Ramos, Teresa L and Torre, Ana G and Osugui, Lika and Rico, Ana and Espinosa‐Lara, Natalia and Gastaca, Irene and Díez‐Campelo, María and Cañizo, Consuelo and Sánchez‐Guijo, Fermín
STEM CELLS, ISSN 1066-5099, 10/2019, Volume 37, Issue 10, pp. 1357 - 1368
Mesenchymal stromal cells (MSC) may exert their functions by the release of extracellular vesicles (EV). Our aim was to analyze changes induced in CD34+ cells... 
Engraftment | Extracellular vesicles | Stem cell transplantation | Mesenchymal stromal cells | Hematopoietic stem cells | Bone marrow | Transplantation | Analysis | Flow cytometry | Phosphorylation | Incorporation | Mesenchyme | Genes | Reverse transcription | Confocal microscopy | Lodging | Macrophages | Kinases | Nanoparticles | Vesicles | CD44 antigen | Cell cycle | Janus kinase | CD34 antigen | Colonies | Diabetes mellitus | Immunodeficiency | Stat5 protein | Electron microscopy | Polymerase chain reaction | Microscopy | Human performance | Stromal cells | Stem cells | Leukocytes (granulocytic) | Apoptosis | Translational and Clinical Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency
by García-Tuñón, Ignacio and Alonso-Pérez, Verónica and Vuelta, Elena and Pérez-Ramos, Sandra and Herrero, María and Méndez, Lucía and Hernández-Sánchez, Jesús María and Martín-Izquierdo, Marta and Saldaña, Raquel and Sevilla, Julián and Sánchez-Guijo, Fermín and Hernández-Rivas, Jesús María and Sánchez-Martín, Manuel
PloS one, 2019, Volume 14, Issue 5, p. e0216674
CRISPR/Cas9 allows the generation of knockout cell lines and null zygotes by inducing site-specific double-stranded breaks. In most cases the DSB is repaired... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity
by Jiménez‐Solas, Tamara and López‐Cadenas, Félix and Aires‐Mejía, Irene and Caballero‐Berrocal, Juan Carlos and Ortega, Rebeca and Redondo, Alba María and Sánchez‐Guijo, Fermín and Muntión, Sandra and García‐Martín, Luís and Albarrán, Beatriz and Alonso, José María and Del Cañizo, Consuelo and Hernández‐Hernández, Ángel and Díez‐Campelo, María
British Journal of Haematology, ISSN 0007-1048, 10/2019, Volume 187, Issue 1, pp. 93 - 104
Summary Patients with low‐risk myelodysplastic syndromes (MDS) usually develop iron overload. This leads to a high level of oxidative stress in the bone marrow... 
iron overload | deferasirox | DNA damage | myelodysplastic syndromes | reactive oxygen species | Genetic research | Analysis | DNA | Flow cytometry | Oxidative stress | Bone marrow | Chelation | Iron | Oxidation | Intracellular | Damage | Differentiation | Deoxyribonucleic acid--DNA | Myelodysplastic syndrome
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency
by Garcia-Tunon, I and Alonso-Perez, V and Vuelta, E and Perez-Ramos, S and Herrero, M and Mendez, L and Hernandez-Sanchez, JM and Martin-Izquierdo, M and Saldana, R and Sevilla, J and Sanchez-Guijo, F and Hernandez-Rivas, JM and Sanchez-Martin, M
PLOS ONE, ISSN 1932-6203, 05/2019, Volume 14, Issue 5, p. e0216674
CRISPR/Cas9 allows the generation of knockout cell lines and null zygotes by inducing site-specific double-stranded breaks. In most cases the DSB is repaired... 
CONSEQUENCES | MUTATIONS | GENE | MULTIDISCIPLINARY SCIENCES | Gene therapy | Usage | CRISPR | Splicing | Exons | Frameshift mutation | Homology | Genomes | mRNA | Gene expression | Zygotes | Efficiency | Cell lines | Alleles | Cell cycle | Non-homologous end joining | Mutation | Deoxyribonucleic acid--DNA | Methods | Cancer | Deoxyribonucleic acid | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients
by Muntión, Sandra and Ramos, Teresa L and Diez-Campelo, María and Rosón, Beatriz and Sánchez-Abarca, Luis Ignacio and Misiewicz-Krzeminska, Irena and Preciado, Silvia and Sarasquete, María-Eugenia and De Las Rivas, Javier and González, Marcos and Sánchez-Guijo, Fermín and Del Cañizo, María-Consuelo
PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, p. e0146722
Exosomes/microvesicles (MVs) provide a mechanism of intercellular communication. Our hypothesis was that mesenchymal stromal cells (MSC) from myelodysplastic... 
ACUTE KIDNEY INJURY | STEM-CELLS | EXTRACELLULAR VESICLES | HEMATOPOIESIS | MECHANISM | MULTIDISCIPLINARY SCIENCES | BONE-MARROW | EXOSOMES | MYELOID-LEUKEMIA PATIENTS | MICRORNAS | EXPRESSION | Antigens, CD34 | Exosomes - metabolism | Gene Expression | Myelodysplastic Syndromes - metabolism | Cell Survival | Humans | Middle Aged | Cell Communication | Cellular Microenvironment | Mesenchymal Stromal Cells - metabolism | Male | MicroRNAs - metabolism | Hematopoietic Stem Cells - metabolism | Hematopoietic Stem Cells - immunology | Aged, 80 and over | Adult | Female | Aged | Myelodysplastic Syndromes - genetics | Stem cells | Physiological aspects | Gas vesicles | Development and progression | Genetic aspects | Research | Myelodysplastic syndromes | Flow cytometry | Intercellular signalling | Mesenchyme | p53 Protein | Leukemia | Crosstalk | Fluorescence | Ultracentrifugation | Confocal | Exosomes | Myelodysplastic syndrome | Cell cycle | DNA methylation | Bone marrow | Communication | CD34 antigen | MDM2 protein | Risk groups | CD63 antigen | MiRNA | Electron microscopy | Gene expression | Patients | Hemopoiesis | Polymerase chain reaction | Cytometry | Properties (attributes) | Transmission electron microscopy | Stromal cells | MicroRNAs | Epigenetics | Viability | Fluorescence microscopy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Biocompatibility of two model elastin‐like recombinamer‐based hydrogels formed through physical or chemical cross‐linking for various applications in tissue engineering and regenerative medicine
by Ibáñez‐Fonseca, Arturo and Ramos, Teresa L and González de Torre, Israel and Sánchez‐Abarca, Luis Ignacio and Muntión, Sandra and Arias, Francisco Javier and Cañizo, María Consuelo and Alonso, Matilde and Sánchez‐Guijo, Fermín and Rodríguez‐Cabello, José Carlos
Journal of Tissue Engineering and Regenerative Medicine, ISSN 1932-6254, 03/2018, Volume 12, Issue 3, pp. e1450 - e1460
Biocompatibility studies, especially innate immunity induction, in vitro and in vivo cytotoxicity, and fibrosis, are often lacking for many novel biomaterials... 
tissue engineering | catalyst‐free click gels | biocompatibility | regenerative medicine | cytocompatibility | elastin‐like recombinamers | silk‐elastin multiblock corecombinamers | elastin-like recombinamers | silk-elastin multiblock corecombinamers | catalyst-free click gels | POLYMERS | STEM-CELLS | CYTOKINES | ARG-GLY-ASP | ENGINEERING, BIOMEDICAL | CELL-ADHESION | DELIVERY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | HEART | BIOMATERIAL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | IN-VIVO | PROTEINS | Proteins | Nuclear magnetic resonance spectroscopy | Biological products | Tissue engineering | Mass spectrometry | Luciferase | Cell proliferation | Bioluminescence | Hydrogels | Toxicity | Cytotoxicity | Inflammatory response | Innate immunity | Immunity | Regeneration (physiology) | Biomaterials | Engineering | Biomedical materials | Biocompatibility | Extracellular matrix | Recombinant | Elastin | Inflammation | Tumor necrosis factor-α | IL-1β | Substrates | Endothelial cells | Medicine | Regeneration | Fibrosis | Mice | In vivo methods and tests | Umbilical vein
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients
by Carlos Santamaría and Sandra Muntión and Beatriz Rosón and Belén Blanco and Olga López-Villar and Soraya Carrancio and Fermín M. Sánchez-Guijo and María Díez-Campelo and Stela Alvarez-Fernández and María E. Sarasquete and Javier de las Rivas and Marcos González and Jesús F. San Miguel and María Consuelo del Cañizo
Haematologica, ISSN 0390-6078, 08/2012, Volume 97, Issue 8, pp. 1218 - 1224
Background Recent findings suggest that a specific deletion of Dicer1 in mesenchymal stromal cell-derived osteoprogenitors triggers several features of... 
DROSHA | DICER | Myelodysplastic syndrome | Mesenchymal stem cells | STEM-CELLS | HEMATOPOIESIS | PATHWAY | mesenchymal stem cells | BONE-MARROW | MDS PATIENTS | myelodysplastic syndrome | HEMATOLOGY | Myelodysplastic Syndromes - metabolism | Ribonuclease III - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Mesenchymal Stromal Cells - metabolism | Male | Gene Expression Profiling | Case-Control Studies | Proteins - genetics | DEAD-box RNA Helicases - genetics | Aged, 80 and over | Female | Aged | MicroRNAs - genetics | Myelodysplastic Syndromes - genetics | Original and Brief Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Regeneration of hyaline cartilage promoted by xenogeneic mesenchymal stromal cells embedded within elastin-like recombinamer-based bioactive hydrogels
by Pescador, David and Ibáñez-Fonseca, Arturo and Sánchez-Guijo, Fermín and Briñón, Jesús G and Arias, Francisco Javier and Muntión, Sandra and Hernández, Cristina and Girotti, Alessandra and Alonso, Matilde and del Cañizo, María Consuelo and Rodríguez-Cabello, José Carlos and Blanco, Juan Francisco
Journal of Materials Science: Materials in Medicine, ISSN 0957-4530, 8/2017, Volume 28, Issue 8, pp. 1 - 11
Over the last decades, novel therapeutic tools for osteochondral regeneration have arisen from the combination of mesenchymal stromal cells (MSCs) and highly... 
Biomedical Engineering | Polymer Sciences | Materials Science | Regenerative Medicine/Tissue Engineering | Ceramics, Glass, Composites, Natural Materials | Surfaces and Interfaces, Thin Films | Biomaterials | OSTEOCHONDRAL DEFECT REPAIR | STEM-CELLS | RABBITS | XENOTRANSPLANTATION | MATERIALS SCIENCE, BIOMATERIALS | IMPLANTATION | ENGINEERING, BIOMEDICAL | MODEL | SCAFFOLDS | TECHNOLOGY | IN-SITU | TRANSPLANTATION | Elastin | Biological products | Resveratrol | Knee | Surgical implants | Hydrogels | Mesenchyme | Sectioning | Cartilage | Mitochondria | Biomedical materials | Computed tomography | Biocompatibility | Lesions | Rabbits | Statistical analysis | Knee (anatomy) | Bone healing | Bone (subchondral) | Biological activity | Regeneration | Magnetic resonance imaging | Stromal cells | Skin & tissue grafts | Resonance | Immunofluorescence
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
by Ramos, Teresa L and Sánchez-Abarca, Luis Ignacio and Rosón-Burgo, Beatriz and Redondo, Alba and Rico, Ana and Preciado, Silvia and Ortega, Rebeca and Rodríguez, Concepción and Muntión, Sandra and Hernández-Hernández, Ángel and De Las Rivas, Javier and González, Marcos and González Porras, José Ramón and Del Cañizo, Consuelo and Sánchez-Guijo, Fermín
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0182470
There is evidence of continuous bidirectional cross-talk between malignant cells and bone marrow-derived mesenchymal stromal cells (BM-MSC), which favors the... 
ORGANIZATION | STEM-CELLS | MULTIDISCIPLINARY SCIENCES | BONE-MARROW NICHE | CORD BLOOD | MYELOID-LEUKEMIA | DIFFERENTIATION | LARGE GENE LISTS | PRIMARY MYELOFIBROSIS | EXPRESSION | MYELODYSPLASTIC SYNDROMES | Gene Expression | Coculture Techniques | Humans | Middle Aged | Male | Hematologic Neoplasms - enzymology | Hematologic Neoplasms - pathology | Cell Cycle | Hematologic Neoplasms - blood | Hematopoiesis | Janus Kinase 2 - metabolism | Biomarkers, Tumor - metabolism | Cell Line, Tumor | Adult | Female | Aged | Biomarkers, Tumor - genetics | Mesenchymal Stromal Cells - physiology | Apoptosis | Mesenchyme | Genes | Fluorescence | Colony-forming cells | Neoplasms | CD90 antigen | CD44 antigen | Janus kinase 2 | Bone marrow | Fibroblasts | Extracellular matrix | CD73 antigen | CD105 antigen | NF-κB protein | Medical research | Cell survival | Colonies | Maintenance | Gene expression | Patients | Hemopoiesis | Stromal cells | Medical prognosis | Cells (biology) | Stem cells | Mutation | Differentiation | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Human bone marrow mesenchymal stromal cells promote bone regeneration in a xenogeneic rabbit model: A preclinical study
by Blanco, Juan Francisco and García-Briñon, Jesús and Benito-Garzón, Lorena and Pescador, David and Muntión, Sandra and Sánchez-Guijo, Fermín
Stem Cells International, ISSN 1687-966X, 2018, Volume 2018, pp. 7089484 - 10
Significant research efforts have been undertaken during the last decades to treat musculoskeletal disorders and improve patient's mobility and quality of... 
TISSUE-ENGINEERED BONE | CRITICAL-SIZE DEFECTS | STEM-CELLS | REPAIR | XENOTRANSPLANTATION | CALCIUM PHOSPHATES | IN-VIVO | ANIMAL-MODELS | BIOMATERIALS | TRICALCIUM PHOSPHATE | CELL & TISSUE ENGINEERING | Surgical implants | Femur | Neurosciences | Osteointegration | Spinal cord | Transplants & implants | Disease | Mesenchyme | Heart surgery | Xenotransplantation | Differentiation (biology) | Defects | Tricalcium phosphate | Bone growth | Biomedical materials | Xenografts | Bone marrow | Biocompatibility | Growth factors | Implantation | Inflammation | Calcium phosphates | Quality of life | Regeneration | Granular materials | Stromal cells | Skin & tissue grafts | Stem cells | Granules | Laboratory animals | Viability
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial
by Jose A. Pérez-Simon and Olga López-Villar and Enrique J. Andreu and José Rifón and Sandra Muntion and María Diez Campelo and Fermín M. Sánchez-Guijo and Carmen Martinez and David Valcarcel and Consuelo del Cañizo
Haematologica, ISSN 0390-6078, 07/2011, Volume 96, Issue 7, pp. 1072 - 1076
This trial evaluated the feasibility and efficacy of the infusion of mesenchymal stem cells expanded using human serum for the treatment of refractory acute or... 
Graft-versus-host disease | Allogeneic stem cell transplant | Mesenchymal stem cells | MARROW | SUBSTITUTE | PLATELET LYSATE | THERAPY | mesenchymal stem cells | CULTURE-CONDITIONS | ANIMAL SERUM | EXPANSION | OPTIMIZATION | REFRACTORY ACUTE GVHD | STROMAL CELLS | HEMATOLOGY | graft-versus-host disease | allogeneic stem cell transplant | Graft vs Host Disease - therapy | Cell Proliferation | Culture Techniques | Humans | Middle Aged | Cells, Cultured | Mesenchymal Stromal Cells - metabolism | Male | Treatment Outcome | Transplantation, Homologous | Young Adult | Mesenchymal Stromal Cells - cytology | Graft vs Host Disease - mortality | Adult | Female | Serum | Aged | Mesenchymal Stem Cell Transplantation | Brief Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: Multicenter randomized controlled clinical trial (phase I/II)
by Lamo-Espinosa, José M and Mora, Gonzalo and Blanco, Juan F and Granero-Moltó, Froilán and Nuñez-Córdoba, Jorge M and Sánchez-Echenique, Carmen and Bondía, José M and Aquerreta, Jesús Dámaso and Andreu, Enrique J and Ornilla, Enrique and Villarón, Eva M and Valentí-Azcárate, Andrés and Sánchez-Guijo, Fermín and Cañizo, María Consuelo and Valentí-Nin, Juan Ramón and Prósper, Felipe
Journal of Translational Medicine, ISSN 1479-5876, 08/2016, Volume 14, Issue 1, p. 246
Background: Mesenchymal stromal cells are a promising option to treat knee osteoarthritis. Their safety and usefulness must be confirmed and the optimal dose... 
Non-surgical management | Knee osteoarthritis | Stem cell therapy | Bone marrow-mesenchymal stromal cells | CRITERIA | MEDICINE, RESEARCH & EXPERIMENTAL | FOLLOW-UP | IDENTIFICATION | CARTILAGE DEFECTS | THERAPY | ARTICULAR-CARTILAGE | CHONDROCYTE IMPLANTATION | REGENERATIVE MEDICINE | STROMAL CELLS | EXPRESSION | Hyaluronic Acid - administration & dosage | Demography | Humans | Middle Aged | Visual Analog Scale | Hyaluronic Acid - pharmacology | Male | Treatment Outcome | Combined Modality Therapy | Osteoarthritis, Knee - therapy | Osteoarthritis, Knee - diagnostic imaging | Mesenchymal Stem Cell Transplantation - adverse effects | Range of Motion, Articular - drug effects | Magnetic Resonance Imaging | Osteoarthritis, Knee - pathology | Injections, Intra-Articular | Female | Aged | Osteoarthritis, Knee - physiopathology | Hyaluronic Acid - adverse effects | Care and treatment | Usage | Stem cells | Clinical trials | Bone marrow | Transplantation | Research | Osteoarthritis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease
by Sánchez-Guijo, Fermín and Caballero-Velázquez, Teresa and López-Villar, Olga and Redondo, Alba and Parody, Rocío and Martínez, Carmen and Olavarría, Eduardo and Andreu, Enrique and Prósper, Felipe and Díez-Campelo, María and Regidor, Carmen and Villaron, Eva and López-Corral, Lucía and Caballero, Dolores and Cañizo, María-Consuelo del and Pérez-Simon, José Antonio
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 10, pp. 1580 - 1585
Abstract We evaluated the feasibility, safety, and efficacy of the administration of 4 sequential doses (intravenously administered on days 1, 4, 11, and 18)... 
Hematology, Oncology and Palliative Medicine | Mesenchymal stromal cells (MSC) | Graft-versus-host disease (GVHD) | STEM-CELLS | STEROID-RESISTANT | ACUTE GVHD | IMMUNOLOGY | SOCIETY | TRANSPLANTATION | TRIAL | CULTURE-CONDITIONS | OPTIMIZATION | HEMATOLOGY | BLOOD | Graft vs Host Disease - therapy | Hematologic Neoplasms - therapy | Prospective Studies | Cell Count | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Hematologic Neoplasms - pathology | Graft vs Host Disease - immunology | Transplantation, Homologous | Mesenchymal Stromal Cells - immunology | Mesenchymal Stromal Cells - cytology | Graft vs Host Disease - mortality | Cryopreservation | Adult | Female | Unrelated Donors | Steroids - therapeutic use | Transplantation Conditioning - methods | Acute Disease | Blood Platelets - chemistry | Treatment Outcome | Graft vs Host Disease - pathology | Survival Analysis | Hematologic Neoplasms - immunology | Mesenchymal Stem Cell Transplantation | Political corruption | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification
by Carrancio, Soraya and López-Holgado, Natalia and Sánchez-Guijo, Fermín M and Villarón, Eva and Barbado, Victoria and Tabera, Soraya and Díez-Campelo, María and Blanco, Juan and San Miguel, Jesús F and del Cañizo, M. Consuelo
Experimental Hematology, ISSN 0301-472X, 2008, Volume 36, Issue 8, pp. 1014 - 1021
Objective Optimization of the mesenchymal stem cells (MSC) isolation and expansion method. Materials and Methods Mononuclear cells (MNC) from bone marrow... 
Hematology, Oncology and Palliative Medicine | Advanced Basic Science | PROGENITOR CELLS | MEDICINE, RESEARCH & EXPERIMENTAL | SUBSTITUTE | CORD BLOOD | TISSUE | HUMAN-BONE-MARROW | FETAL CALF SERUM | PERIPHERAL-BLOOD | HYPOXIA | HEMATOLOGY |